• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Respiratory/Inflammation

The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials.  For more information on both of these therapy areas please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next
  • expand A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled AZD8683 After Single Ascending Doses in Healthy Male Subjects
    Study Id
    D1883C00001
    Disease
    asthma
    Drug Name
    AZD8683
    Study Name
    D1883C00001
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A double-blind, placebo controlled, randomised, parallel group, phase IIa study to investigate the efficacy, tolerability and safety of 8 doses of AZD8848 administered intranasally once weekly over 7 weeks in mild to moderate asthma patients challenged with an inhaled allergen.
    Study Id
    D0540C00003
    Disease
    asthma
    Drug Name
    AZD8848
    Study Name
    D0540C00003
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A double-blind, placebo controlled, randomized, parallel group study to investigate the tolerability, safety, pharmacodynamics and pharmacokinetics of repeated weekly doses of AZD8848 administered intranasally to seasonal allergic rhinitis patients
    Study Id
    D0540C00001
    Disease
    asthma
    Drug Name
    AZD8848
    Study Name
    D0540C00001
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Fostamatinib Disodium in Healthy Japanese and White Subjects After Single and Multiple Ascending Doses
    Study Id
    D4300C00007
    Drug Name
    Fostamatinib Disodium
    Study Name
    D4300C00007
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand An Open-label, Single-Centre Study to Assess the Pharmacokinetics of R406 in Healthy Volunteers When Fostamatinib Disodium 150 mg is Administered Alone and in Combination With Verapamil
    Study Id
    D4300C00011
    Disease
    rheumatoid arthritis
    Drug Name
    Fostamatinib Disodium
    Study Name
    D4300C00011
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma
    Study Id
    D4300C00024
    Disease
    lymphoma
    Drug Name
    Fostamatinib Disodium
    Study Name
    C-935788-017
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies
    Study Id
    D4300C00021
    Disease
    rheumatoid arthritis
    Drug Name
    Fostamatinib Disodium
    Study Name
    C-935788-012
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, open label, fixed sequence, single centre study in healthy volunteers to investigate the effects of repeated oral doses AZD9668 on the pharmacokinetics and pharmacodynamics of a single dose of warfarin
    Study Id
    D0520C00013
    Drug Name
    AZD9668
    Study Name
    D0520C00013
    Recruiting Status
    Not Yet Recruiting
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication
    Study Id
    S43
    Disease
    asthma
    Drug Name
    non drug study (respiratory)
    Study Name
    S43
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A randomized, multicenter, placebo and active-controlled, single-dose, 4-period, crossover study to evaluate the bronchodilating effect of SYMBICORT pMDI versus Advair Diskus and Ventolin HFA.
    Study Id
    SD-039-0733
    Disease
    asthma
    Drug Name
    Symbicort
    Study Name
    SD-039-0733
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013